Table 1.

Univariate analysis of the main characteristics for AOSD patients and controls.

Variables	AOSD patients, n = 80 %	Controls, n = 60 %	P	Odds ratio [CI 95%]
Age	33.76 ± 13	39.5 ± 14		0.01
Sex-ratio M/F	0.63	0.46		–
Deterioration of general condition	67/80 (83.7)	32/60 (53.3)	9 × 10−5	4.5 [1.9–10.6]
Fever	80/80 (100)	46/60 (76.7)	5 × 10−6	–
T, 39°C–40°C	76/80 (95)	28/46 (60.8)	<10−6	12.2 [3.5–47.1]
Hectic fever	58/80 (72.5)	5/46 (10.8)	<10−6	21.6 [6.9–71,9]
Rash	70/80 (87.5)	26/60 (43.3)	<10−6	9.5 [3.7–23.2]
Typical rash	38/70 (54.3)	2/26 (7.7)	<3 × 10−5	14.2 [2.9–94.7]
Atypical rash	32/70 (45.7)	24/26 (92.3)	3 × 10−5	0.1 [0.01–0.34]
Macular rash	59/70 (84.3)	3/26 (11.5)	<10−6	41.12 [9.3–210.3]
Transient rash	64/70 (91.4)	8/26 (30.7)	<10−6	24 [6.5–95.5]
Sore throat	66/80 (82.5)	10/60 (16.6)	<10−6	23.6 [8.9–64.3]
Arthralgia	75/80 (93.8)	53/60 (88.3)	.2	1.9 [0.5–7.7]
Myalgia	55/80 (68.8)	27/60 (45)	.004	2.7 [1.3–5.7]
Arthritis	54/80 (67.5)	15/60 (25)	10−5	6.2 [2.8–14.2]
N° pain joints	11.6 ± 8.7	5.62 ± 4.5	10−5	–
N° swollen joints	4.9 ± 4.2	3.3 ± 2.5	.1	–
Liver dysfunction	57/80 (71.2)	27/60 (45)	.001	3 [1.4–6.5]
Lymphadenopathy	16/80 (20)	6/60 (10)	.1	2.5 [0.8–6.9]
Splenomegaly	11/80 (13.8)	2/60 (3.3)	.03	4.6 [0.9–31.5]
Pleuritis	10/80 (12.5)	3/60 (05)	.1	2.7 [0.6–13.1]
Pericarditis	14/80 (17.5)	5/60 (8.3)	.1	2.3 [0.7–7.9]